Source:http://linkedlifedata.com/resource/pubmed/id/16155120
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2005-10-3
|
pubmed:abstractText |
Oral carmofur, either as a single or in combination with other chemotherapeutic agents, has been used as adjuvant chemotherapy for curatively resected colon cancer patients. Past trials and meta-analyses indicate that it is somewhat effective in extending survival of patients with this cancer. The objective of this study was to perform a reappraisal of randomized clinical trials conducted in this regard.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0368-2811
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
536-44
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16155120-Antineoplastic Agents,
pubmed-meshheading:16155120-Chemotherapy, Adjuvant,
pubmed-meshheading:16155120-Colonic Neoplasms,
pubmed-meshheading:16155120-Digestive System Surgical Procedures,
pubmed-meshheading:16155120-Disease-Free Survival,
pubmed-meshheading:16155120-Fluorouracil,
pubmed-meshheading:16155120-Humans,
pubmed-meshheading:16155120-Neoplasm Recurrence, Local,
pubmed-meshheading:16155120-Prognosis,
pubmed-meshheading:16155120-Randomized Controlled Trials as Topic,
pubmed-meshheading:16155120-Survival Rate
|
pubmed:year |
2005
|
pubmed:articleTitle |
An individual patient data meta-analysis of adjuvant therapy with carmofur in patients with curatively resected colon cancer.
|
pubmed:affiliation |
Department of Epidemiological and Clinical Research Information Management, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8501, Japan. sakamoto@pbh.med.kyoto-u.ac.jp
|
pubmed:publicationType |
Journal Article,
Meta-Analysis
|